New data on pixantrone Phase III trial in non-Hodgkin's lymphoma to be presented

[News]

Cell Therapeutics, Inc. (CTI) announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present new data on the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) at the 51st Annual Meeting of the American Society of Hematology on Saturday, December 5, 2009 in New Orleans, Louisiana.

More... (http://www.news-medical.net/news/20091202/New-data-on-pixantrone-Phase-III-trial-in-non-Hodgkins-lymphoma-to-be-presented.aspx)